Oracea Capsule
Product Images NDC 0299-3822

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oracea (NDC 0299-3822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galderma Laboratories, L.p., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

P56801 0 Production Proof 2249 Page 1

Oracea is a type of drug available in capsule form. It contains various inactive ingredients such as Hypromellose, Iron Oxide Red, Iron Oxide Yellow, Methacrylic Acid Copolymer, Polystyrene Glycol, Polysorbate 80, Super Spheres, Talc, Thanium Dioxide, and Triathyl Citrate. One capsule of Oracea should be taken daily and stored under controlled room temperature between 15°C - 30°C (59F - 86°F). The medicine should be kept out of reach of children. It contains 30 mg of immediate release and 10 mg of delayed release beads. The manufacturer of Oracea is Galderma Laboratories, L.P., located in Fort Worth, Texas, USA.*

FDA Label Image

Oracea-chem-struct (Oracea Chem Struct)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.